Obeticholic acid price and efficacy analysis

Obeticholic acid (Obeticholic acid) is a selective farnesoid Recent studies have shown that some biochemical indicators, immunological indicators and clinical symptoms of patients with refractory PBC may improve after receiving obeticholic acid treatment, but there are certain differences in the results of different research institutions.

In treatment studies, indicators such as alkaline phosphatase, bilirubin, and aminotransferase are widely used to evaluate treatment effects and primary endpoints. The results of multiple studies show that the incidence rate of the primary endpoint in patients receiving combination therapy was 61.3%, which was higher than the 42.3% rate in the monotherapy group. In addition, obeticholic acid use is associated with a decrease in serum IgM levels. However, research results on serum C-reactive protein (CRP) levels show different trends. Some trials found no significant differences in CRP levels between obeticholic acid and placebo, while other studies showed that obeticholic acid treatment was associated with significant improvements in CRP. A meta-analysis of published studies confirmed that combination therapy resulted in significantly lower serum CRP levels than UDCA monotherapy. These results highlight the potential importance of combination therapy in improving the overall prognosis of patients with PBC.

Currently, obeticholic acid has not yet received marketing approval in China, so it cannot be included in medical insurance, and the specific selling price has not yet been announced. In the international market, the original drug of obeticholic acid mainly comes in two specifications: 5 mg 30 tablets and 10 mg 30 tablets. The price usually exceeds 20,000 yuan. The specific price will change due to exchange rate fluctuations. The high cost of original drugs puts many patients under financial pressure.

It is worth noting that generic drugs of obeticholic acid have appeared in overseas markets. The ingredients of these generic drugs are similar to the original drugs. Suppliers include ASEAN Pharmaceuticals in Laos, Beacon Pharmaceuticals in Bangladesh and Mylan Pharmaceuticals in India. In comparison, the prices of these generic drugs are relatively affordable, usually ranging from a few hundred to a thousand yuan, but they are also affected by exchange rate fluctuations. In general, the price and efficacy of obeticholic acid are important factors that patients need to consider when choosing a treatment option.

References:https://journals.lww.com/eurojgh/fulltext/2020/09000/combination_therapy_of_obeticholic_acid_and.6.aspx